These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Richert ND; Ostuni JL; Bash CN; Leist TP; McFarland HF; Frank JA Mult Scler; 2001 Feb; 7(1):49-58. PubMed ID: 11321194 [TBL] [Abstract][Full Text] [Related]
13. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis. Pitzalis C; Sharrack B; Gray IA; Lee A; Hughes RA J Neuroimmunol; 1997 Apr; 74(1-2):62-8. PubMed ID: 9119980 [TBL] [Abstract][Full Text] [Related]
15. Is interferon gamma suppression after cardiac surgery caused by a decreased interleukin-12 synthesis? Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A Ann Thorac Surg; 2006 Jul; 82(1):103-9. PubMed ID: 16798198 [TBL] [Abstract][Full Text] [Related]
16. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment]. Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835 [TBL] [Abstract][Full Text] [Related]
17. Corticosteroid-depending effects on peripheral immune cell subsets vary according to disease modifying strategies in multiple sclerosis. Höpner L; Proschmann U; Inojosa H; Ziemssen T; Akgün K Front Immunol; 2024; 15():1404316. PubMed ID: 38938576 [TBL] [Abstract][Full Text] [Related]
18. High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients. Dufour A; Salmaggi A; La Mantia L; Eoli M; Nespolo A; Milanese C Int J Neurosci; 1994 Mar; 75(1-2):119-28. PubMed ID: 7914185 [TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta. Hussien Y; Sanna A; Söderström M; Link H; Huang YM Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948 [TBL] [Abstract][Full Text] [Related]
20. Methylprednisolone treatment, immune activation, and intrathecal inflammation in multiple sclerosis. Sellebjerg F Dan Med Bull; 2004 May; 51(2):167-83. PubMed ID: 16009055 [No Abstract] [Full Text] [Related] [Next] [New Search]